Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · IEX Real-Time Price · USD
53.29
-0.96 (-1.77%)
At close: May 17, 2024, 4:00 PM
53.28
-0.01 (-0.02%)
After-hours: May 17, 2024, 4:00 PM EDT

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $264.25M in the twelve months ending March 31, 2024, with 31.52% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $70.50M with 28.99% year-over-year growth. In the year 2023, Immunocore Holdings had annual revenue of $249.43M with 43.05% growth.

Revenue (ttm)
$264.25M
Revenue Growth
+31.52%
P/S Ratio
10.09
Revenue / Employee
$531,698
Employees
497
Market Cap
2.67B USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-1.16M-3.08%
Dec 31, 202037.64M5.56M17.32%
Dec 31, 201932.09M2.52M8.52%
Dec 31, 201829.57M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
Evolent Health 2.18B
Azenta 651.76M
Inari Medical 520.66M
TG Therapeutics 289.33M
Twist Bioscience 277.49M
Arcellx 131.66M
Merus 38.34M
Revenue Rankings

IMCR News

More News